OR WAIT 15 SECS
November 27, 2020
The pharmaceutical company has submitted a New Drug Application for dihydroergotamine mesylate for fast and lasting whole migraine relief in adults with and without aura.
November 18, 2020
A study presented during PAINWeek 2020 Live Virtual Conference highlights the role of e-consultations in reducing opioid use.
November 11, 2020
Add value by optimizing medications, decreasing pill burden.
November 04, 2020
Often what parents reach for to relieve a child’s pain or fever, a new meta-analysis looks at the efficacy and safety of ibuprofen and acetaminophen.
October 22, 2020
A virtual session held during the NCPA 2020 Annual Convention discussed best practices for handling opioid prescriptions.
October 19, 2020
The agency warns that use of NSAIDs around 20 weeks or later in pregnancy may cause rare but serious kidney problems in an unborn baby.
October 14, 2020
Oliceridine (Olinvyk; Trevena, Inc) is an intravenous opioid agonist indicated in adults for management of acute severe pain in a hospital or controlled clinical setting.
October 13, 2020
The rate of prescribing opioids among both oncologists and non-oncologists has dropped significantly in the past few years.
October 12, 2020
Pharmacists are uniquely qualified to ensure patients receive sufficient pain relief.
September 17, 2020
Pharmacists, nurses, and physicians work together to combat the overuse of powerful pain relievers.
September 09, 2020
Tramadol hydrochloride (Qdolo; Athena Bioscience) oral solution is indicated for use when pain is severe enough to require an opioid analgesic and for which alternative treatments are inadequate.
August 12, 2020
In a collaborative effort, the American Pharmacists Association and Walmart are offering free online training on opioid stewardship to all pharmacists and pharmacy technicians.
August 10, 2020
The COVID-19 crisis poses unique challenges for managing controlled substances in hospitals.
The opioid’s indication was based on several randomized controlled trials, where patients reported decreased pain.
August 06, 2020
The grants are part of the administration’s continuing focus on rural health initiatives.
July 27, 2020
Responding to growing interest by industry stakeholders, the agency has offered draft guidance outlining quality considerations and other practical recommendations for cannabis and cannabis-derived compounds.
Health care professionals should consider prescribing naloxone to patients taking prescribed opioids who are at increased risk of opioid overdose, according to the FDA.
July 24, 2020
Eighty-one percent of opioid abuse referrals to post-acute care facilities in Massachusetts were rejected, investigators found.
An inside look at the process from prescription to dispensing.
July 17, 2020
Once largely stigmatized, illicit substances are breaking into the field of pain management.
